<code id='BCE53B88CE'></code><style id='BCE53B88CE'></style>
    • <acronym id='BCE53B88CE'></acronym>
      <center id='BCE53B88CE'><center id='BCE53B88CE'><tfoot id='BCE53B88CE'></tfoot></center><abbr id='BCE53B88CE'><dir id='BCE53B88CE'><tfoot id='BCE53B88CE'></tfoot><noframes id='BCE53B88CE'>

    • <optgroup id='BCE53B88CE'><strike id='BCE53B88CE'><sup id='BCE53B88CE'></sup></strike><code id='BCE53B88CE'></code></optgroup>
        1. <b id='BCE53B88CE'><label id='BCE53B88CE'><select id='BCE53B88CE'><dt id='BCE53B88CE'><span id='BCE53B88CE'></span></dt></select></label></b><u id='BCE53B88CE'></u>
          <i id='BCE53B88CE'><strike id='BCE53B88CE'><tt id='BCE53B88CE'><pre id='BCE53B88CE'></pre></tt></strike></i>

          explore

          explore

          author:explore    Page View:2629
          Trump Campaign Event In Nevada
          Ethan Miller/Getty Images

          WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.

          In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.

          advertisement

          “Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          comprehensive

          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more
          American taxpayers paid $1.8 trillion in health care costs in 2022
          American taxpayers paid $1.8 trillion in health care costs in 2022

          AdobeAmericantaxpayersfootedthebillforatleast$1.8trillioninfederalandstatehealthcareexpendituresin20

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          A preacher's new calling: Diversifying neuroscience research

          TheauthorpreachingatUnionBaptistChurchinBaltimore.CourtesyEvelynJ.ChatmonWhenIwasthepastorofalargeBa